| RETRACTED: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas X Zhang, X Zhao, W Fiskus, J Lin, T Lwin, R Rao, Y Zhang, JC Chan, K Fu, ... Cancer cell 22 (4), 506-523, 2012 | 323 | 2012 |
| A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis X Tan, W Qin, L Zhang, J Hang, B Li, C Zhang, J Wan, F Zhou, K Shao, ... Clinical cancer research 17 (21), 6802-6811, 2011 | 218 | 2011 |
| microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin Z Chen, X Zhao, J Wang, B Li, Z Wang, J Sun, F Tan, D Ding, X Xu, ... Journal of Biological Chemistry 286 (12), 10725-10734, 2011 | 206 | 2011 |
| Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma X Zhao, T Lwin, A Silva, B Shah, J Tao, B Fang, L Zhang, K Fu, C Bi, J Li, ... Nature communications 8 (1), 14920, 2017 | 149 | 2017 |
| MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma X Xu, Z Chen, X Zhao, J Wang, D Ding, Z Wang, F Tan, X Tan, F Zhou, ... Biochemical and biophysical research communications 421 (4), 640-645, 2012 | 148 | 2012 |
| Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity X Zhao, T Lwin, X Zhang, A Huang, J Wang, VE Marquez, S Chen-Kiang, ... Leukemia 27 (12), 2341-2350, 2013 | 125 | 2013 |
| miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression DP Ding, ZL Chen, XH Zhao, JW Wang, J Sun, Z Wang, FW Tan, XG Tan, ... Carcinogenesis 32 (7), 1025-1032, 2011 | 125 | 2011 |
| PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas Y Ren, C Bi, X Zhao, T Lwin, C Wang, J Yuan, AS Silva, BD Shah, B Fang, ... The Journal of clinical investigation 128 (12), 5517-5530, 2018 | 86 | 2018 |
| Pin1 expression contributes to lung cancer prognosis and carcinogenesis X Tan, F Zhou, J Wan, J Hang, Z Chen, B Li, C Zhang, K Shao, P Jiang, ... Cancer biology & therapy 9 (2), 111-119, 2010 | 83 | 2010 |
| A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas T Lwin, X Zhao, F Cheng, X Zhang, A Huang, B Shah, Y Zhang, ... The Journal of clinical investigation 123 (11), 4612-4626, 2013 | 82 | 2013 |
| BCL2 amplicon loss and transcriptional remodeling drives ABT-199 resistance in B cell lymphoma models X Zhao, Y Ren, M Lawlor, BD Shah, PMC Park, T Lwin, X Wang, K Liu, ... Cancer Cell 35 (5), 752-766. e9, 2019 | 73 | 2019 |
| c-MYC–miRNA circuitry: a central regulator of aggressive B-cell malignancies J Tao, X Zhao, J Tao Cell Cycle 13 (2), 191-198, 2014 | 65 | 2014 |
| Resistance to Ibrutinib in B cell malignancies: one size does not fit all B Shah, X Zhao, AS Silva, KH Shain, J Tao Trends in cancer 4 (3), 197-206, 2018 | 19 | 2018 |
| Venetoclax as a single agent and in combination with PI3K-MTOR1/2 kinase inhibitors against ibrutinib sensitive and resistant mantle cell lymphoma (MCL) H Jiang, T Lwin, X Zhao, Y Ren, G Li, L Moscinski, B Shah, J Tao British journal of haematology 184 (2), 298, 2019 | 17 | 2019 |
| Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma X Zhao, MY Wang, H Jiang, T Lwin, PM Park, J Gao, MB Meads, Y Ren, ... Cell reports 34 (11), 2021 | 15 | 2021 |
| Combined treatment of BTK and PI3K inhibitors synergistically disrupts BCR-signaling, overcomes microenviroment-mediated survival and drug resistance in mantle cell lymphoma. J Tao, T Lwin, X Zhao, B Shah, L Zhang, L Moscinski, W Dalton, ... Cancer Research 73 (8_Supplement), 4944-4944, 2013 | 12 | 2013 |
| Response and resistance to CDK12 inhibition in aggressive B-cell lymphomas J Gao, MY Wang, Y Ren, T Lwin, T Li, JC Yan, EM Sotomayor, DR Duckett, ... haematologica 107 (5), 1119, 2022 | 9 | 2022 |
| A five-microRNA signature for squamous cell lung carcinoma (SCC) diagnosis and Hsa-miR-31 for SCC prognosis X Tan, W Qin, L Zhang, J Hang, B Li, C Zhang, J Wan, F Zhou, K Shao, ... Clin Cancer Res 17 (21), 6802-11, 2011 | 8 | 2011 |
| JQ 1, a selective bromodomain inhibitor, decreased the expression of the tolerogenic molecule PDL1 in antigen-presenting cells (APCs) and restores the responsiveness of anergic … H Wang, F Cheng, L Xing, X Zhao, A Villagra, J Pinilla-Ibarz, J Tao Blood, The Journal of the American Society of Hematology 124 (21), 2749-2749, 2014 | 7 | 2014 |
| MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas MY Wang, T Li, Y Ren, BD Shah, T Lwin, J Gao, KH Shain, W Zhang, ... Blood Cancer Journal 11 (1), 14, 2021 | 6 | 2021 |
